How Will Trump’s H-1B Executive Order Impact Infosys, Cognizant, And Accenture?
The US administration has issued an executive order radically changing the H-1B visa program. Effective immediately, a one-year entry ban has been placed on H-1B visa holders unless they pay a $100,000 fee upon entry. Furthermore, all new applications and extensions must pay $100,000 for processing, followed by an annual $100,000 maintenance fee. This unprecedented move has sent shockwaves across the technology, healthcare, and higher education sectors that depend heavily on skilled foreign talent. Listed IT companies like Infosys, Cognizant, and Accenture face some of the most immediate risks, with their stocks already reacting negatively in anticipation of higher costs and talent disruptions.
About Cognizant And Market Sensitivity
Cognizant Technology Solutions (NASDAQ: CTSH) is one of the biggest employers of H-1B visa holders in the United States. With a workforce heavily reliant on Indian professionals, the executive order directly threatens its cost structure and service delivery capabilities. Cognizant has already seen its stock fall over 4% in recent sessions, reflecting investor anxiety. If enforced long-term, the policy could force Cognizant to accelerate local hiring at higher wages, which would likely squeeze margins and profitability.
Details Of The Executive Order
The order includes several key provisions:
- Travel Ban: Starting September 21st, no H-1B visa holder may enter the US for one year unless a $100,000 fee is paid.
- Annual Fees: New and existing visas will require $100,000 per year in fees to remain valid.
- Suspension Of Processing: The Department of Homeland Security (DHS) will halt new H-1B processing until further notice.
Implications For Infosys And Accenture
Infosys (NSE: INFY, NYSE: INFY) and Accenture (NYSE: ACN) also rely heavily on US-based projects. Infosys, which derives more than 60% of its revenue from North America, faces a significant cost challenge. Its ADRs have already slipped sharply in anticipation of margin compression. Accenture, while more globally diversified, still employs thousands of H-1B workers in the US, and investors fear reduced flexibility in staffing projects.
Sectoral Impact Beyond IT
The effects are not limited to IT companies. US healthcare systems, universities, and research institutions that depend on H-1B professionals are warning of labor shortages. The policy could also push multinational corporations to relocate more operations outside the United States, weakening America’s competitiveness in critical industries.
Mid-Article Market Insight
The order is likely to face legal challenges in US courts. Until clarity emerges, IT stocks may remain volatile. For now, institutional investors appear to be pricing in higher operational risks for Indian IT companies with strong US dependencies.
Investor Takeaway
Trump’s executive order on H-1B visas represents one of the most disruptive policy changes for the Indian IT industry in decades. Infosys, Cognizant, and Accenture are among the most exposed, with immediate impacts already visible in share prices. While long-term strategy shifts like local hiring and automation may help, near-term risks are substantial. Investors should expect heightened volatility and closely follow both legal challenges and corporate responses to this policy shock.
For deeper insights into market reactions and investment strategy, visit Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
